regadenoson has been researched along with triamterene in 1 studies
| Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (triamterene) | Trials (triamterene) | Recent Studies (post-2010) (triamterene) |
|---|---|---|---|---|---|
| 321 | 53 | 264 | 1,212 | 181 | 86 |
| Protein | Taxonomy | regadenoson (IC50) | triamterene (IC50) |
|---|---|---|---|
| Janus kinase 2 (a protein tyrosine kinase) | Homo sapiens (human) | 4.613 | |
| Cathepsin G | Homo sapiens (human) | 7.413 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
| Caspase-1 | Homo sapiens (human) | 3.663 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for regadenoson and triamterene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |